IBDEI2RZ ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,44262,0)
 ;;=F16.959^^164^2191^9
 ;;^UTILITY(U,$J,358.3,44262,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44262,1,3,0)
 ;;=3^Hallucinogen Induced Psychotic D/O w/o Use D/O
 ;;^UTILITY(U,$J,358.3,44262,1,4,0)
 ;;=4^F16.959
 ;;^UTILITY(U,$J,358.3,44262,2)
 ;;=^5003356
 ;;^UTILITY(U,$J,358.3,44263,0)
 ;;=F16.99^^164^2191^17
 ;;^UTILITY(U,$J,358.3,44263,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44263,1,3,0)
 ;;=3^Hallucinogen Related D/O,Unspec
 ;;^UTILITY(U,$J,358.3,44263,1,4,0)
 ;;=4^F16.99
 ;;^UTILITY(U,$J,358.3,44263,2)
 ;;=^5133359
 ;;^UTILITY(U,$J,358.3,44264,0)
 ;;=F16.983^^164^2191^16
 ;;^UTILITY(U,$J,358.3,44264,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44264,1,3,0)
 ;;=3^Hallucinogen Persisting Perception D/O
 ;;^UTILITY(U,$J,358.3,44264,1,4,0)
 ;;=4^F16.983
 ;;^UTILITY(U,$J,358.3,44264,2)
 ;;=^5003358
 ;;^UTILITY(U,$J,358.3,44265,0)
 ;;=F16.21^^164^2191^20
 ;;^UTILITY(U,$J,358.3,44265,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44265,1,3,0)
 ;;=3^Hallucinogen Use DO,Mod/Sev,In Remiss
 ;;^UTILITY(U,$J,358.3,44265,1,4,0)
 ;;=4^F16.21
 ;;^UTILITY(U,$J,358.3,44265,2)
 ;;=^5003337
 ;;^UTILITY(U,$J,358.3,44266,0)
 ;;=F16.11^^164^2191^18
 ;;^UTILITY(U,$J,358.3,44266,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44266,1,3,0)
 ;;=3^Hallucinogen Use DO,Mild,In Remiss
 ;;^UTILITY(U,$J,358.3,44266,1,4,0)
 ;;=4^F16.11
 ;;^UTILITY(U,$J,358.3,44266,2)
 ;;=^268239
 ;;^UTILITY(U,$J,358.3,44267,0)
 ;;=F11.10^^164^2192^25
 ;;^UTILITY(U,$J,358.3,44267,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44267,1,3,0)
 ;;=3^Opioid Use DO,Mild,Uncomp
 ;;^UTILITY(U,$J,358.3,44267,1,4,0)
 ;;=4^F11.10
 ;;^UTILITY(U,$J,358.3,44267,2)
 ;;=^5003114
 ;;^UTILITY(U,$J,358.3,44268,0)
 ;;=F11.129^^164^2192^22
 ;;^UTILITY(U,$J,358.3,44268,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44268,1,3,0)
 ;;=3^Opioid Intox w/o Perceptual Dists w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,44268,1,4,0)
 ;;=4^F11.129
 ;;^UTILITY(U,$J,358.3,44268,2)
 ;;=^5003118
 ;;^UTILITY(U,$J,358.3,44269,0)
 ;;=F11.14^^164^2192^5
 ;;^UTILITY(U,$J,358.3,44269,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44269,1,3,0)
 ;;=3^Opioid Induced Depressive D/O w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,44269,1,4,0)
 ;;=4^F11.14
 ;;^UTILITY(U,$J,358.3,44269,2)
 ;;=^5003119
 ;;^UTILITY(U,$J,358.3,44270,0)
 ;;=F11.182^^164^2192^11
 ;;^UTILITY(U,$J,358.3,44270,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44270,1,3,0)
 ;;=3^Opioid Induced Sleep D/O w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,44270,1,4,0)
 ;;=4^F11.182
 ;;^UTILITY(U,$J,358.3,44270,2)
 ;;=^5003124
 ;;^UTILITY(U,$J,358.3,44271,0)
 ;;=F11.20^^164^2192^28
 ;;^UTILITY(U,$J,358.3,44271,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44271,1,3,0)
 ;;=3^Opioid Use DO,Mod/Sev,Uncomp
 ;;^UTILITY(U,$J,358.3,44271,1,4,0)
 ;;=4^F11.20
 ;;^UTILITY(U,$J,358.3,44271,2)
 ;;=^5003127
 ;;^UTILITY(U,$J,358.3,44272,0)
 ;;=F11.23^^164^2192^26
 ;;^UTILITY(U,$J,358.3,44272,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44272,1,3,0)
 ;;=3^Opioid Use DO,Mod/Sev w/ Withdrawal
 ;;^UTILITY(U,$J,358.3,44272,1,4,0)
 ;;=4^F11.23
 ;;^UTILITY(U,$J,358.3,44272,2)
 ;;=^5003133
 ;;^UTILITY(U,$J,358.3,44273,0)
 ;;=F11.24^^164^2192^6
 ;;^UTILITY(U,$J,358.3,44273,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44273,1,3,0)
 ;;=3^Opioid Induced Depressive D/O w/ Mod/Sev Use D/O
 ;;^UTILITY(U,$J,358.3,44273,1,4,0)
 ;;=4^F11.24
 ;;^UTILITY(U,$J,358.3,44273,2)
 ;;=^5003134
